- SPANNR
- Posts
- Issue #34
Issue #34
Issue #34
January 19, 2023 | Issue #34
Good evening. Welcome back to another issue of Spannr – where we strive to become the easiest place to stay up to date on age-defying research, life extension trends, and the biggest health story of all time.In this week's newsletter:📌 Genetics vs. Lifestyle📢 This week's funding announcements✨ Good reads from around the web
Longevity Science: Is It Based On Genetics?
The study of longevity, and the factors that contribute to it, has become a topic of increasing interest in recent years.Advances in genetic research, as well as a deeper understanding of the impact of lifestyle and environmental factors, have led to new insights into how we can potentially extend our healthy lifespan.But what influences one's longevity more? Genetic or non-genetic factors?In our latest article, we search for the answer... and delve a bit more into the fundamental principles behind healthy aging.
BIOHM, a company utilizing microbiome data to create new products and ingredients to help individuals live healthier lives, raised $7.5 Million to accelerate microbiome research, AI capabilities and product development
EIP Pharma, a clinical-stage company focused on developing treatments for neurodegenerative diseases, announced that the National Institute on Aging (NIA) awarded the company a grant of $21 million to support a 160-patient phase 2b study of neflamapimod in individuals with dementia with Lewy bodies (DLB)
UN urges nations to prepare for an aging world now (Axios)
Visualizing the Changing World Population, by Country (Visual Capitalist)
Life expectancy can have a greater impact than even record-high inflation on how long your retirement savings will last (CNBC)
Reprogramming stem cells to heal disease (Mayo Clinic)
AgeTech at CES 2023 -- Who led the charge? (Gerontechnologist)
Two research teams reverse signs of aging in mice (Science)
Meet the Techstars Future of Longevity Class of 2023 (Techstars)
The Lifelong Power of Close Relationships (WSJ)
Moving Longevity To The Mainstream – Through Mice, Leading Ladies And Movies (Forbes)
How to Spot and Avoid Fraudulent Longevity Supplements (Healthnews)
The NIH Should Launch a Clinical Trial Committee (The Good Science Project)
Performance:
Latest Price: $123.097d-Return: -0.59% Market Cap: $12.61b